At diagnosis, between 70 and 90% of children with T1DM have evidence of an immune-mediated process with islet-cell autoantibodies against glutamic acid decarboxylase 65 (GAD), islet antigen 2 (IA2), or insulin autoantibodies (IAA) [7]. This evidence concerns the gene PTPRN and type 1 diabetes mellitus.